27F0 fundamentals
An in-depth look to Kala Pharmaceuticals Inc. operating, investing, and financing activities
27F0 free cash flow for Q1 24 is -10.06 M EUR. For 2023, 27F0 free cash flow was -25.85 M EUR and operating cash flow was -25.3 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM